DIA

The preliminary programme for the 2024 DIA Middle East & North Africa (MENA) Conference is now available! Join us in Cairo, Egypt, on 26-27 November for an unparalleled opportunity to engage with key stakeholders in the pharmaceutical sector. This year’s conference will bring together health authorities, industry leaders, academics, and patient representatives to explore the unique opportunities and challenges in the MENA region. Topics include: ◾ Regional regulatory and reliance developments ◾ Digital transformation, AI and RWE ◾ Rare diseases ◾ Advanced therapies ◾ eLabelling ◾ Supply chain and sample management ◾ And much more! Don’t miss out on this great chance to collaborate, connect, and learn from over 300 participants representing countries across the region. Access the full programme here: https://bit.ly/3yQlcD1. #DIAMENA2024 #PharmaInnovation #HealthcareLeadership #MENARegion #RegulatoryScience

The 2024 DIA India Annual Meeting is right around the corner! This year, we are thrilled to host a lineup of leading experts who will dive into the latest in medical devices, pharmacovigilance, regulatory sciences, and clinical topics. Expect engaging sessions on AI, regulatory challenges, and innovative strategies that will shape the future of healthcare. Connect with top professionals, share insights, and explore new opportunities. Check out our website for the full list of speakers and secure your spot today: https://bit.ly/4bR5YM0. Vinod Mattoo Pravin Nath Dr.Rajesh Kumawat Susan Korah Amrit Gill, MD MBA Anupam Chhabra, MD, MBA Dr Ritu Singal M.D Dr Ashok Swain Nishank Nivedit #DIAIndia #Pharmacovigilance #Clinical #RegulatoryAffairs #MedicalDevices

FREE WEBINAR: EU Combination Products - Opportunities and Challenges Bringing combination products to the European market is a complex endeavor, often hindered by regulatory challenges. These obstacles can stifle innovation, creating significant barriers to market entry. In this session from DIA Europe 2024, experts from the Medical Products Agency, EMA and industry share their insights on the current regulatory hurdles and discuss potential pathways to foster innovation in the European market. Interested in this topic? Watch the full session on-demand and join us at DIA Europe 2025 to continue these critical discussions. ◾ Access the webinar: https://bit.ly/3Xeh60Q. ◾ Learn more about DIA Europe 2025: https://bit.ly/3xbhliT. #DIAEurope #Learning #CombinationProducts #LifeSciences

It's time to elevate your edge this season by connecting, learning, and growing in your expertise at our events across the Americas. Here's what's in the queue for this fall... Global Clinical Trial Disclosure and Data Transparency Conference September 23-24 | Arlington, VA Advance Rates expire today! Latin America Annual Meeting September 25-26 | Brasília, Brazil Real-World Evidence Conference October 24-25 | Philadelphia, PA DIA/FDA Oligonucleotide-based Therapeutics Conference October 28-30 | Washington, DC Canada Annual Meeting November 14-15 | Gatineau, QC View more details ➡ https://lnkd.in/eZ68Eqpq

Don’t miss our FREE QPPV Talks Webinar on 26 September! Join us for an insightful 45-minute webinar featuring Ilaria Grisoni (Jazz Pharmaceuticals) and Gabrielle Amselem (Alexion, AstraZeneca Rare Disease) as they share their expertise on critical pharmacovigilance topics. Get a preview of the key discussions set for the DIA Global QPPV Forum and gain valuable insights into the field. Follow our page for the latest updates and register now to secure your spot! Cláudia Ferreira #QPPVForum2024 #QPPVTalks #Pharmacovigilance #DrugSafety #PSMF

Are you interested in the evolving landscape of pharmacovigilance? Join our ‘Artificial Intelligence in Pharmacovigilance’ training course to learn about the latest technological advancements in this field. In this course, we will cover: ◾ How pharmacovigilance and its technologies are changing. ◾ Various AI technologies, including ChatGPT. ◾ Management perspectives and challenges, including people, skills, governance, audits, and compliance. ◾ Current PV IT platforms and their capabilities in AI and automation. ◾ Envisioning the ideal PV IT intelligence system of the future. The early bird is ending on 26 August. Register now and save: https://bit.ly/4g7PTEP. #Pharmacovigilance #DrugSafety #IT #ArtificialIntelligence #AI

We're teaming up with Regulatory Affairs Professionals Society (RAPS) to explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena — including research, development and manufacturing — in Europe for decades to come. We're pleased to announce that registration is now open for the 2024 #RegulatoryPolicyForum, an event from DIA and RAPS this December. Learn more about this new event and get your ticket here: https://bit.ly/3YMFisn.

As Keynote Speakers at the DIA 2024 Global Annual Meeting, Emily and Tom Whitehead recently shared the story of Emily’s battle with acute lymphoblastic leukemia and her inspiring journey as the first pediatric CAR T-cell therapy patient. Their moving presentation urged companies and drug manufacturers to increase awareness and communication about clinical trials and new therapies to help more patients have access to innovative treatments. Emily also shared her personal testimony to motivate researchers and developers to continue their vital work, knowing that their dedication directly impacts the lives of patients and families. “We like to put a face to who everyone this industry is helping,” Tom said. The Whiteheads continue to share their journey at industry conferences around the globe to help turn Emily’s survivor story into tens of thousands of survivor stories. Carie Pierce